BiaCure Therapies
Company Details
Status: Private
Employees: 1-10
Location:
Milwaukee, Wisconsin, United States
Type:
sample
Technology:
sample
sample
sample
About: Onychomycosis is a pervasive, disfiguring, and often painful infection of the nail, surface of the nail bed, and/or nail matrix caused by fungi that are ubiquitous in the environment
Over 35 million patients in the US suffer from this type of infection, including approximately 1 in 3 diabetic patients. Research demonstrates an increased risk of other foot disorders and amputations in diabetic patients with onychomycosis.
There are no current treatments that effectively treat this type of infection.
Our patented TherawaveTM 100 technology delivers a safe and effective High Frequency Energy (HFE) precisely to the infected nail plate and surface nail bed to eliminate the fungal infection while sparing surrounding tissue.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BiaCure Therapies | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.